ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic valueVANDESOMPELE, Jo; EDSJÖ, Anders; DE PRETER, Katleen et al.Oncogene (Basingstoke). 2003, Vol 22, Num 3, pp 456-460, issn 0950-9232, 5 p.Article

From chromosomes to molecular karyotyping : Identification of an unbalanced X-autosome translocation by array CGH in a boy with a syndromic form of chondrodysplasia punctata brachytelephalangictypeMENTEN, Björn; BUYSSE, Karen; VANDESOMPELE, Jo et al.European journal of medical genetics. 2005, Vol 48, Num 3, pp 301-309, issn 1769-7212, 9 p.Article

Accurate prediction of neuroblastoma outcome based on miRNA expression profilesSCHULTE, Johannes H; SCHOWE, Benjamin; DE PRETER, Katleen et al.International journal of cancer (Print). 2010, Vol 127, Num 10, pp 2374-2385, issn 0020-7136, 12 p.Article

Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53VAN MAERKEN, Tom; FERDINANDE, Liesbeth; MARINE, Jean-Christophe et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 22, pp 1562-1574, issn 0027-8874, 13 p.Article

Report of a female patient with mental retardation and tall stature due to a chromosomal rearrangement disrupting the OPHN1 gene on Xql2MENTEN, Björn; BUYSSE, Karen; VERMEULEN, Stefan et al.European journal of medical genetics. 2007, Vol 50, Num 6, pp 446-454, issn 1769-7212, 9 p.Article

Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1MAERTENS, Ophélia; DE SCHEPPER, Sofie; VANDESOMPELE, Jo et al.American journal of human genetics. 2007, Vol 81, Num 2, pp 243-251, issn 0002-9297, 9 p.Article

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastomaVAN MAERKEN, Tom; SPELEMAN, Frank; MARINE, Jean-Christophe et al.Cancer research (Baltimore). 2006, Vol 66, Num 19, pp 9646-9655, issn 0008-5472, 10 p.Article

Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinomaVAN GELE, Mireille; BOYLE, Glen M; SPELEMAN, Frank et al.Oncogene (Basingstoke). 2004, Vol 23, Num 15, pp 2732-2742, issn 0950-9232, 11 p.Article

Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiationEDSJÖ, Anders; NILSSON, Helén; VANDESOMPELE, Jo et al.Laboratory investigation. 2004, Vol 84, Num 4, pp 406-417, issn 0023-6837, 12 p.Article

Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA levelPYFFEROEN, Lotte; MESTDAGH, Pieter; VERGOTE, Karl et al.International journal of cancer (Print). 2014, Vol 135, Num 12, pp 2868-2877, issn 0020-7136, 10 p.Article

High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary NeuroblastomaSCHULTE, Johannes H; BACHMANN, Hagen S; VANDESOMPELE, Jo et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5082-5092, issn 1078-0432, 11 p.Article

Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- NeuroblastomaBUCKLEY, Patrick G; ALCOCK, Leah; SPELEMAN, Frank et al.Clinical cancer research (Print). 2010, Vol 16, Num 11, pp 2971-2978, issn 1078-0432, 8 p.Article

Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic CompoundsDE PRETER, Katleen; DE BROUWER, Sara; VAN MAERKEN, Tom et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3690-3696, issn 1078-0432, 7 p.Article

Rapid detection of VHL exon deletions using real-time quantitative PCRHOEBEECK, Jasmien; VAN DER LUIJT, Rob; VANDESOMPELE, Jo et al.Laboratory investigation. 2005, Vol 85, Num 1, pp 24-33, issn 0023-6837, 10 p.Article

MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AALTHOFF, Kristina; BECKERS, Anneleen; SCHRAMM, Alexander et al.International journal of cancer (Print). 2013, Vol 133, Num 5, pp 1064-1073, issn 0020-7136, 10 p.Article

Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomasFIEUW, Annelies; KUMPS, Candy; BUCKLEY, Patrick G et al.International journal of cancer (Print). 2012, Vol 130, Num 11, pp 2599-2606, issn 0020-7136, 8 p.Article

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN AmplificationDE BROUWER, Sara; DE PETER, Katleen; DE PAEPE, Anne et al.Clinical cancer research (Print). 2010, Vol 16, Num 17, pp 4353-4362, issn 1078-0432, 10 p.Article

Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomicsVANDESOMPELE, Jo; MICHELS, Evi; DE PAEPE, Anne et al.International journal of cancer. 2008, Vol 122, Num 5, pp 1177-1182, issn 0020-7136, 6 p.Article

High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsHOEBEECK, Jasmien; MICHELS, Evi; LAUREYS, Geneviève et al.International journal of cancer. 2007, Vol 120, Num 3, pp 533-538, issn 0020-7136, 6 p.Article

Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosisHELLEMANS, Jan; PREOBRAZHENSKA, Olena; SAVARIRAYAN, Ravi et al.Nature genetics. 2004, Vol 36, Num 11, pp 1213-1218, issn 1061-4036, 6 p.Article

Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaDE BROUWER, Sara; MESTDAGH, Pieter; VANDESOMPELE, Jo et al.International journal of cancer (Print). 2012, Vol 130, Num 11, pp 2591-2598, issn 0020-7136, 8 p.Article

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene SignatureDE PRETER, Katleen; VERMEULEN, Joëlle; NAKAGAWARA, Akira et al.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1532-1541, issn 1078-0432, 10 p.Article

Comparison of miRNA profiles of microdissected Hodgkin/ Reed-Sternberg cells and Hodgkin cell lines versus CD77⁺ B-cells reveals a distinct subset of differentially expressed miRNAsVAN VLIERBERGHE, Pieter; AN DE WEER; POPPE, Bruce et al.British journal of haematology. 2009, Vol 147, Num 5, pp 686-690, issn 0007-1048, 5 p.Article

Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma OutcomeSCHRAMM, Alexander; VANDESOMPELE, Jo; SCHULTE, Johannes H et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1459-1465, issn 1078-0432, 7 p.Article

Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cellsSWERTS, Katrien; DE MOERLOOSE, Barbara; DHOOGE, Catharina et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 3, pp 438-445, issn 0009-9147, 8 p.Article